Abbott India Limited is a healthcare company engaged in pharmaceuticals business. The Company has a portfolio of science-based offerings in diagnostics, medical devices, nutritionals and branded generic pharmaceuticals. Its business operations are divided into four business divisions: Women's Health & Gastrointestine, Gastroenterology and Hepatic Care; Specialty Care; GenNext & Vaccines, and Consumer Care. Women's Health & Gastrointestine, Gastroenterology and Hepatic Care division has a mix of global and local brands present in the pregnancy, constipation and liver diseases segments. The Specialty Care division consists of a range of products in the treatment of central nervous system and metabolic disorders. The GenNext division focuses on several therapy areas, including pain management, vitamins and pregnancy. Its vaccines include Enteroshield (typhoid vaccine) and Rotasure (rotavirus diarrhea vaccine). The Consumer Care division is present in the over the counter antacid segment.
Co.'s principal activity is the provision of foreign exchange services for corporates exposed to currency market volatility through its 100%. owned subsidiary, Alpha FX Limited. Activities range from initial design and implementation of hedging strategies, to ongoing management and monitoring of currency risks.
Lonza supplies services and products that range from active pharmaceutical ingredients and stem-cell therapies to drinking water sanitizers, from vitamin B compounds and organic personal care ingredients to agricultural products, and from industrial preservatives to microbial control solutions. Co. operates in two segments: Lonza Pharma & Biotech, which clusters all of Co.'s offerings for pharmaceutical markets, focuses on providing custom development, custom manufacturing, cell therapy, viral therapeutics and bioscience solutions; and Lonza Specialty Ingredients, which includes offerings in its consumer care, agro ingredients, industrial solutions, wood protection and water treatment.
Menicon is a contact lens manufacturer which engaged in the manufacture and sale of contact lenses and related products. Co. manufactures and sells rigid gas permeable contact lenses, soft contact lenses, and disposal contact lenses of 1 day disposal type, 2 weeks exchange type, and 1 month exchange type, as well as contact lens care products such as contact lens cleaner, disinfectant solution and preservation solution. Co. offers a fixed-rate membership system "MELS Plan" to provide guarantee services for loss, damage, and lens power change. In addition, Co. is also engaged in the veterinary business, environmental biotechnology business, and life science business.
Novo-Nordisk is a global healthcare company engaged in the innovation of diabetes care. Co. also provides haemophilia care, growth hormone therapy and hormone replacement therapy. The Diabetes care business segment includes research, development, manufacturing and marketing of products within the areas of insulin, GLP-1 and related delivery systems, oral antidiabetic products (OAD) and obesity. The Biopharmaceuticals business segment includes research, development, manufacturing and marketing of products within the areas of haemophilia, growth hormone therapy, hormone replacement therapy, inflammation therapy and other therapy areas.
Recticel is engaged in the production of a variety of polyurethane foams that are used in the furniture, technical, automotive, bedding and insulation industries. The Flexible Foam Business Line covers the manufacture, conversion and marketing of flexible polyurethane foam. The types of flexible foams are classified as Comfort, Technical Foams and Composite Foams. Co. is also engaged in the manufacture of foams used in mattresses and slat bases. In addition, Co. manufactures rigid polyurethane and phenolic foams for thermal insulation. Co.'s automotive activities include: manufacturing moulded seat cushions, window encapsulation and manufacturing interior trim components.
Rogers designs, develops, manufactures and sells engineered materials and components. The company's segments are: Advanced Connectivity Solutions, which designs, develops, manufactures and sells circuit materials and solutions enabling connectivity for applications in wireless infrastructure, automotive, aerospace and defense, connected devices, and wired infrastructure; Elastomeric Material Solutions, which designs, develops, manufactures and sells engineered material solutions such as polyurethane and silicone materials used in cushioning; and Power Electronics Solutions, which designs, develops, manufactures and sells ceramic substrate materials, busbars and cooling solutions.
Shokubun is engaged in the food business. Co. and its subsidiaries operate in three business segments. Food Retailing segment is engaged in the sale of commercial foods, delivery of food materials, as well as the provision of plannings and management to franchised members. Co. covers delivery services in the Tokyo metropolitan area, Aichi, Gifu, Mie, Shiga, Kyoto and Osaka, Japan. Food Research Study and Wholesaling segment is involved in the research and study of food and food-related issues, as well as the wholesaling of food products, household products, gifts and novelty products. Nursing Food Business segment is engaged in the sale and advice of nursing food in the nursing facilities.
Tecan provides laboratory instruments and automation solutions. Co. also provides solutions for various applied markets such as forensics, the food industry, crop research, the cosmetic industry and veterinary applications. Co.'s automation solutions include instruments, software packages, and configurable modules as well as regulatory and quality consulting, service and consumables. Co.'s segments include life sciences business, which supplies end users with automated workflow solutions directly; and partnering, which develops and manufactures OEM instruments and components that are distributed by partner companies under their own names.
Vermilion Research delivers timely, actionable, and unique research inputs to professional investors. Our research strategists highlight securities which we believe are at major inflection points, based on our various proprietary technical indicators, and offer asymmetric risk/return profiles. We believe our research methodology, which is not limited by industry sector or market capitalization, enables us to deliver superior investment recommendations.
Our process begins by organizing all actively traded stocks into coherent sectors, then into logical industry groups. We then apply our proprietary relative strength tools to identify developing price trends. Once attractive trends are identified within a selected sectors or groups, we screen for individual stocks which we believe offer the best risk/reward profile. Vermilion offers U.S. and global equity market research products. Vermilion’s research team, which has received numerous awards and accolades, has a combined 70 year of experience in the analysis of investment securities.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.